Dr. Afsaneh Lavasanifar

Dr. Afsaneh Lavasanifar is expert in pharmaceutics and drug delivery. She is a professor in the Pharmaceutical Sciences division of the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta and has a joint appointment with the Department of Chemical and Medical Engineering at the Faculty of Engineering at the same university.

She is also the Scientific Chief Officer and Vice President of Meros Pharma, a spinoff company based on the technology developed in her lab. Her research has been funded by grants from Natural Science and Engineering Council of Canada (NSERC), Canadian Institute of Health Research (CIHR), Canadian Foundation for Innovation (CFI); Alberta Innovates Health Solutions (AIHS) and Alberta Cancer Foundation (ACF).

About Dr. Lavasanifar

Lavasanifar Lab

Design and development of innovative delivery technologies to improve drug performance with a particular focus on

nanotechnology for improving cancer therapy.

Dr. Mohammad Reza Vakili
Research Associate

Research title:

Engineering of different polymer based drug delivery systems

Research Positions

Nasim Sarrami
PhD Student

Research title:

Development of nano-theranostics for targeted sensitization of solid tumors to to DNA damaging therapeutics

Parnian Mehinrad
MSc Student

Research title:

Development of nano-delivery systems of novel inhibitors of DNA repair for sensitization of colorectal cancer to DNA damage

Sirazum Munira
PhD Student

Research title:

Development of stimulus responsive hybrid nano-delivery systems

Graduate Students

Sara Abd El-Hafeez
PhD Student

Research title:

The synergistic and immunogenic effect of PNKP inhibitors and their nano-formulations to anti tumor effects of DNA damaging therapies in colorectal cancer